Vanguard Group Inc Sellas Life Sciences Group, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,513,235 shares of SLS stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,513,235
Previous 1,147,324
31.89%
Holding current value
$1.77 Million
Previous $1.22 Million
25.66%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SLS
# of Institutions
35Shares Held
8.03MCall Options Held
2.52MPut Options Held
24.7K-
Anson Funds Management LP Dallas, TX4.83MShares$5.65 Million0.8% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$360,9053.71% of portfolio
-
Black Rock Inc. New York, NY278KShares$325,5150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA273KShares$319,4830.0% of portfolio
-
Opus Capital Group, LLC201KShares$234,7020.03% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...